Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [31] Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021
    Plumb, Ian D.
    Fette, Lida M.
    Tjaden, Ashley H.
    Feldstein, Leora
    Saydah, Sharon
    Ahmed, Amina
    Link-Gelles, Ruth
    Wierzba, Thomas F.
    Berry, Andrea A.
    Friedman-Klabanoff, DeAnna
    Larsen, Moira P.
    Runyon, Michael S.
    Ward, Lori M.
    Santos, Roberto P.
    Ward, Johnathan
    Weintraub, William S.
    Edelstein, Sharon
    Uschner, Diane
    VACCINE, 2023, 41 (15) : 2596 - 2604
  • [32] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
  • [33] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    VACCINES, 2021, 9 (03) : 1 - 13
  • [34] Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
    Satarker S.
    Ahuja T.
    Banerjee M.
    E V.B.
    Dogra S.
    Agarwal T.
    Nampoothiri M.
    Current Pharmacology Reports, 2020, 6 (5) : 203 - 211
  • [35] Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2
    Krsak, Martin
    Harry, Brian L.
    Palmer, Brent E.
    Franco-Paredes, Carlos
    VIRAL IMMUNOLOGY, 2021, 34 (08) : 504 - 509
  • [36] Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
    Kang, Yeon-Woo
    Park, Subin
    Lee, Kun-Joo
    Moon, Dain
    Kim, Young-Min
    Lee, Seung-Woo
    IMMUNE NETWORK, 2021, 21 (01) : 1 - 16
  • [37] Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Lee, Eunjin
    Oh, Ji Eun
    MOLECULES AND CELLS, 2021, 44 (07) : 392 - 400
  • [38] SARS-CoV-2/COVID-19: a primer for cardiologists
    de Vries, A. A. F.
    NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 366 - 383
  • [39] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2025, 51 (01) : 139 - 156
  • [40] Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Lee, Eunjin
    Oh, Ji Eun
    MOLECULES AND CELLS, 2021, 44 (06) : 392 - 400
12345